Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Novel Therapeutic Approach by Nicotine in Experimental Model of Multiple Sclerosis.
Assessment of urinary incontinence in the women in Eastern Turkey.
Guillain-Barre syndrome masquerading as acute respiratory failure in an infant.
Safety of TNF inhibitors in adolescents and children.
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis.
The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases.
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses.
Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden.
Increased expression of Aquaporin 4 in the rat hippocampus and cortex during trimethyltin-induced neurodegeneration.
Both positive and negative effects on immune responses by expression of a second class II MHC molecule.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
Vitamin D in allergic disorders.
Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran.
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
Predicting outcome in clinically isolated syndrome using machine learning.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
Novel therapeutics in multiple sclerosis management: clinical applications.
Exercise barriers and preferences among women and men with multiple sclerosis.
Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation.
Pages
« first
‹ previous
…
461
462
463
464
465
466
467
468
469
…
next ›
last »